Medtronic launches Beacon HF monitoring service

Medtronic (NYSE:MDT) said today it launched its Beacon heart failure management service in the U.S., designed to monitor data from cardiac pacing devices to improve early interventions before heart failure events. The service, which integrates data from the company’s implantable cardioverter defibrillator and cardiac resynchronization therapy devices, will allow patients to engage in daily health checks to both educate patients about conditions and to collect symptoms and biometrics. “Beacon is a significant advance in our heart failure management arsenal. With its combination of valuable device diagnostics, day-to-day patient status and symptoms, and expert oversight of a trained care manager, Beacon allows clinicians to better identify, evaluate, and potentially intervene with their high-risk heart failure patients,” Dr. Jawwad Yusuf of The Stern Cardiovascular Foundation said in a prepared statement. Care managers from Fridley, Minn.-based Medtronic will evaluate incoming data and monitor for increasing risks of heart failure to alert providers appropriately, and will provide monthly reports to physicians summarizing the patient’s health information. “Healthcare systems are under increasing pressure to improve patient care while also driving down associated cost. MCMS is committed to helping our customers deliver better patient outcomes while addressing these challenges. Our technologies – and the data and insights they generate –...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Cardiac Assist Devices Cardiac Implants Cardiovascular Patient Monitoring Medtronic Source Type: news